{"id":580172,"date":"2025-06-18T23:32:39","date_gmt":"2025-06-19T06:32:39","guid":{"rendered":"https:\/\/nai500.com\/?p=580172"},"modified":"2025-06-18T23:32:39","modified_gmt":"2025-06-19T06:32:39","slug":"%e6%8e%98%e9%87%91%e5%9f%ba%e5%9b%a0%e5%89%aa%e5%88%80%ef%bc%9a%e8%81%9a%e7%84%a6%e4%ba%94%e5%8f%aacrispr%e5%9f%ba%e5%9b%a0%e7%bc%96%e8%be%91%e6%8a%80%e6%9c%afetf","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2025\/06\/%e6%8e%98%e9%87%91%e5%9f%ba%e5%9b%a0%e5%89%aa%e5%88%80%ef%bc%9a%e8%81%9a%e7%84%a6%e4%ba%94%e5%8f%aacrispr%e5%9f%ba%e5%9b%a0%e7%bc%96%e8%be%91%e6%8a%80%e6%9c%afetf\/","title":{"rendered":"\u6398\u91d1\u201c\u57fa\u56e0\u526a\u5200&#8221;\uff1a\u805a\u7126\u4e94\u53eaCRISPR\u57fa\u56e0\u7f16\u8f91\u6280\u672fETF"},"content":{"rendered":"<p>\u76ee\u524d\uff0cCRISPR\u57fa\u56e0\u7f16\u8f91\u6280\u672f\u6709\u6f5c\u529b\u901a\u8fc7\u4fee\u6539DNA\u6765\u7ea0\u6b63\u7a81\u53d8\uff0c\u4ece\u800c\u6539\u53d8\u591a\u79cd\u75be\u75c5\u7684\u6cbb\u7597\u65b9\u5f0f\uff0c\u751a\u81f3\u53ef\u80fd\u6cbb\u6108\u75be\u75c5\u3002\u5982\u6b64\u98a0\u8986\u6027\u7684\u751f\u547d\u79d1\u5b66\u6280\u672f\u9769\u547d\uff0c\u81ea\u7136\u4f1a\u5438\u5f15\u4f17\u591a\u6295\u8d44\u8005\u7684\u5173\u6ce8\u3002\u5bf9\u4e8e\u60f3\u8981\u7701\u5fc3\uff0c\u540c\u65f6\u5206\u6563\u98ce\u9669\u7684\u6295\u8d44\u8005\u6765\u8bf4\uff0c\u8ffd\u8e2aCRISPR\u4ee5\u53ca\u66f4\u5e7f\u6cdb\u57fa\u56e0\u7f16\u8f91\u6280\u672f\u7684\u4ea4\u6613\u6240\u4ea4\u6613\u57fa\u91d1\uff08ETF\uff09\u5c31\u662f\u4e0d\u4e8c\u4e4b\u9009\u3002<\/p>\n<p>\u53ef\u4f9b\u6295\u8d44\u8005\u8d2d\u4e70\u7684\u751f\u7269\u6280\u672fETF\u4e0d\u5c11\uff0c\u4f46\u4e13\u6ce8\u4e8eCRISPR\u548c\u57fa\u56e0\u7f16\u8f91\u6280\u672f\u7684ETF\u6570\u91cf\u76f8\u5bf9\u6709\u9650\u3002\u4ee5\u4e0b\u662f\u4e13\u6ce8CRISPR\u57fa\u56e0\u7f16\u8f91\u7684\u524d\u4e94\u5927ETF\uff08\u6570\u636e\u622a\u81f32025\u5e746\u670813\u65e5\uff09\u3002<\/p>\n<table>\n<thead>\n<tr>\n<td><strong>ETF\u540d\u79f0<\/strong><\/td>\n<td><strong>\u8d39\u7387<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=ARKG\">ARK Genomic Revolution ETF (NYSEMKT:ARKG)<\/a><\/td>\n<td>0.75%<\/td>\n<\/tr>\n<tr>\n<td>Global X Genomics &amp; Biotechnology ETF (NASDAQ:GNOM)<\/td>\n<td>0.5%<\/td>\n<\/tr>\n<tr>\n<td>Invesco Dynamic Biotechnology &amp; Genome ETF (NYSEMKT:PBE)<\/td>\n<td>0.58%<\/td>\n<\/tr>\n<tr>\n<td>iShares Genomics Immunology and Healthcare ETF (NYSEMKT:IDNA)<\/td>\n<td>0.47%<\/td>\n<\/tr>\n<tr>\n<td>WisdomTree BioRevolution Fund (BATS:WDNA)<\/td>\n<td>0.45%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>1.\u00a0 ARK Genomic Revolution ETF (ARKG)<\/h2>\n<p>\u8be5ETF\u662f\u7531\u6728\u5934\u59d0\u7684ARK Invest\u8bbe\u7acb\u7684\u591a\u53eaETF\u4e4b\u4e00\u3002\u8fd9\u662f\u4e00\u53ea\u4e3b\u52a8\u7ba1\u7406\u578bETF\uff0c\u4e13\u6ce8\u4e8e\u90a3\u4e9b\u5c06\u57fa\u56e0\u7ec4\u5b66\u878d\u5165\u4e1a\u52a1\u4ece\u800c\u53d7\u76ca\u7684\u516c\u53f8\u3002\u8be5ETF\u7684\u7b2c\u4e8c\u5927\u6301\u4ed3\u662fCRISPR\u57fa\u56e0\u7f16\u8f91\u9886\u57df\u7684\u5148\u9a71\u2014\u2014CRISPR Therapeutics (CRSP)\uff0c\u4ee5\u53ca\u76f8\u5173\u7684\u5236\u836f\u516c\u53f8\u80a1\u7968\uff0c\u5305\u62ecBeam Therapeutics (BEAM)\u3001Intellia Therapeutics (NTLA)\u3001\u518d\u751f\u5143\u5236\u836f (REGN)\uff08\u4e0eIntellia\u5408\u4f5c\uff09\u4ee5\u53ca\u798f\u6cf0\u5236\u836f (VRTX)\u3002<\/p>\n<p>2023\u5e7412\u6708\uff0c\u798f\u6cf0\u5236\u836f\u4e0eCRISPR Therapeutics\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6279\u51c6\uff0c\u5c06CRISPR\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5Casgevy\u7528\u4e8e\u6cbb\u7597\u9570\u72b6\u7ec6\u80de\u75c5\u30022024\u5e741\u6708\uff0c\u8fd9\u4e24\u5bb6\u5408\u4f5c\u4f19\u4f34\u53c8\u83b7\u5f97FDA\u6279\u51c6\uff0c\u5c06\u8be5\u7597\u6cd5\u7528\u4e8e\u6cbb\u7597\u8f93\u8840\u4f9d\u8d56\u6027\u03b2\u5730\u4e2d\u6d77\u8d2b\u8840\u3002<\/p>\n<h2>2.\u00a0 Global X Genomics &amp; Biotechnology ETF (GNOM)<\/h2>\n<p>\u8be5ETF\u7531\u97e9\u56fd\u6295\u8d44\u516c\u53f8Mirae Asset Financial Group\u8fd0\u8425\uff0c\u65e8\u5728\u6295\u8d44\u90a3\u4e9b\u5c06\u4ece\u57fa\u56e0\u7ec4\u5b66\u8fdb\u6b65\uff08\u5305\u62ec\u57fa\u56e0\u7f16\u8f91\u548c\u57fa\u56e0\u7ec4\u6d4b\u5e8f\u7684\u7a81\u7834\uff09\u4e2d\u53d7\u76ca\u7684\u516c\u53f8\u3002GNOM\u76ee\u524d\u6301\u670949\u53ea\u80a1\u7968\uff0c\u5176\u4e2d\u4e94\u5bb6\u2014\u2014CRISPR Therapeutics\u3001\u798f\u6cf0\u5236\u836f\u3001Intellia Therapeutics\u3001Beam Therapeutics\u548cVerve Therapeutics (VERV)\u2014\u2014\u6b63\u5728\u9500\u552e\u6216\u5f00\u53d1CRISPR\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5\u3002\u53e6\u5916\u4e24\u5bb6\u6301\u4ed3\u516c\u53f8Genscript\u548cAgilent (A) \u5411\u836f\u7269\u5f00\u53d1\u5546\u548c\u7814\u7a76\u4eba\u5458\u63d0\u4f9bCRISPR\u4ea7\u54c1\u548c\u670d\u52a1\u3002<\/p>\n<h2>3.\u00a0 Invesco Dynamic Biotechnology &amp; Genome ETF (PBE)<\/h2>\n<p>\u8be5ETF\u65e8\u5728\u8ffd\u8e2a\u4e00\u4e2a\u5305\u542b30\u5bb6\u7f8e\u56fd\u751f\u7269\u6280\u672f\u548c\u57fa\u56e0\u7ec4\u516c\u53f8\u7684\u6307\u6570\u3002PBE\u7684\u524d\u5341\u5927\u6301\u4ed3\u4e2d\uff0c\u6709\u4e24\u5bb6\u4e0e\u57fa\u56e0\u7f16\u8f91\u76f8\u5173\uff1a\u798f\u6cf0\u5236\u836f\u548c\u5409\u5229\u5fb7\u79d1\u5b66 (GILD)\u3002\u798f\u6cf0\u4e0eCRISPR Therapeutics\u5408\u4f5c\u9500\u552eCRISPR\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5Casgevy\u3002\u5409\u5229\u5fb7\u5219\u4e0eSangamo Therapeutics (SGMO) \u5408\u4f5c\uff0c\u5229\u7528Sangamo\u7684\u950c\u6307\u6838\u9178\u9176\uff08ZFN\uff09\u57fa\u56e0\u7f16\u8f91\u65b9\u6cd5\uff08\u4e00\u79cd\u6bd4CRISPR\u66f4\u65e9\u7684\u6280\u672f\uff09\u5f00\u53d1\u764c\u75c7\u7ec6\u80de\u7597\u6cd5\u3002<\/p>\n<h2>4.\u00a0 iShares Genomics Immunology and Healthcare ETF (IDNA)<\/h2>\n<p>\u8be5ETF\u8ffd\u8e2a\u4e00\u4e2a\u805a\u7126\u4e8e\u57fa\u56e0\u7ec4\u5b66\u3001\u514d\u75ab\u5b66\u548c\u751f\u7269\u5de5\u7a0b\u9886\u57df\u7684\u53d1\u8fbe\u53ca\u65b0\u5174\u5e02\u573a\u516c\u53f8\u6307\u6570\u3002\u76ee\u524d\u6301\u670951\u5bb6\u5236\u836f\u548c\u751f\u7269\u6280\u672f\u516c\u53f8\u7684\u80a1\u7968\u3002\u8be5ETF\u7684\u6301\u4ed3\u5305\u62ec\u524d\u8ff0\u4e94\u5bb6\u4e0eCRISPR\u57fa\u56e0\u7f16\u8f91\u76f8\u5173\u7684\u516c\u53f8\u80a1\u7968\uff1aCRISPR Therapeutics\u3001Verve Therapeutics\u3001Beam Therapeutics\u3001Intellia Therapeutics\u548c\u518d\u751f\u5143\u5236\u836f\u3002<\/p>\n<h2>5.\u00a0 WisdomTree BioRevolution Fund (WDNA)<\/h2>\n<p>\u8be5ETF\u65e8\u5728\u8ffd\u8e2a\u4e00\u4e2a\u7531\u201c\u5c06\u56e0\u9057\u4f20\u5b66\u548c\u751f\u7269\u6280\u672f\u8fdb\u6b65\u800c\u53d1\u751f\u91cd\u5927\u53d8\u9769\u201d\u7684\u516c\u53f8\u7ec4\u6210\u7684\u6307\u6570\u3002\u4e0e\u5176\u4ed6ETF\u7c7b\u4f3c\uff0cWDNA\u5e76\u4e0d\u4ec5\u9650\u4e8eCRISPR\u6216\u57fa\u56e0\u7f16\u8f91\u7c7b\u80a1\u7968\u3002\u9664\u4e86Beam Therapeutics\u3001CRISPR Therapeutics\u3001\u5409\u5229\u5fb7\u79d1\u5b66\u3001Intellia Therapeutics\u3001\u518d\u751f\u5143\u5236\u836f\u3001\u798f\u6cf0\u5236\u836f\u548cVerve Therapeutics\uff0c\u5b83\u8fd8\u6301\u6709\u963f\u65af\u5229\u5eb7 (AZN) \u548cCaribou Biosciences (CRBU) \u8fd9\u4e24\u5bb6\u5728\u5f00\u53d1CRISPR\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5\u7684\u516c\u53f8\u80a1\u7968\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u76ee\u524d\uff0cCRISPR\u57fa\u56e0\u7f16\u8f91\u6280\u672f\u6709\u6f5c\u529b\u901a\u8fc7\u4fee\u6539DNA\u6765\u7ea0\u6b63\u7a81\u53d8\uff0c\u4ece\u800c\u6539\u53d8\u591a\u79cd\u75be\u75c5\u7684\u6cbb\u7597\u65b9\u5f0f\uff0c\u751a\u81f3\u53ef\u80fd\u6cbb\u6108\u75be\u75c5\u3002\u5982 [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":569421,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[2190,455,747,925],"class_list":["post-580172","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-etf-sch","tag-455","tag-747","tag-925","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/580172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=580172"}],"version-history":[{"count":1,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/580172\/revisions"}],"predecessor-version":[{"id":580177,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/580172\/revisions\/580177"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/569421"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=580172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=580172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=580172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}